SCHEMBL28823621

SCHEMBL28823621

CS(=O)(=O)c1cc(-c2cccc(N)c2N)ccn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 2/20 0.36
▸ JAK2 O60674 1/20 0.34
▸ ROCK1 Q13464 1/20 0.34
▸ PIK3C3 Q8NEB9 1/20 0.34
▸ NR1H2 P55055 2/20 0.33
▸ NR1H3 Q13133 2/20 0.33
▸ ALOX5AP P20292 1/20 0.33
▸ FEN1 P39748 1/20 0.33
▸ PIK3CD O00329 1/20 0.33
▸ PIP5K1C O60331 1/20 0.33
▸ PIK3CB P42338 1/20 0.33
▸ PI4KA P42356 1/20 0.33
▸ PIK3CG P48736 1/20 0.33
▸ PI4KB Q9UBF8 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ EPHB4 P54760 1/20 0.32
▸ PTK2 Q05397 1/20 0.32
▸ FYN P06241 1/20 0.32
▸ MINK1 Q8N4C8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21463384 0.76 TDO2 (0.46) MAP4K4PIK3CB
SCHEMBL28488492 0.73 IDO1 (0.39) MAP4K4ALOX5APFEN1FYNMAPK10
SCHEMBL30615364 0.73 IDO1 (0.39) MAP4K4ALOX5APFEN1FYNMAPK10
SCHEMBL5700203 0.73 PLAU (0.41) MAP4K4PTGS1PTGS2
SCHEMBL3491279 0.71 PTGS2 (0.59) JAK2PTGS1PTGS2
Dimethyl Sulfone SCHEMBL28028274 0.71 ALDH1A1 (0.54) PTGS1PTGS2
SCHEMBL2643084 0.70 L3MBTL1 (0.42) MAP4K4ROCK1PIK3C3PIK3CDPIP5K1C
SCHEMBL15550019 0.70 HRH3 (0.44) ROCK1PIK3CDPIP5K1CPIK3CBPI4KA
SCHEMBL12075926 0.69 PTGS2 (0.34) ROCK1PIK3C3PIK3CDPIP5K1CPIK3CB
SCHEMBL30808436 0.69 ALDH1A1 (0.53) JAK2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105431419-A Novel aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection HOFFMANN-LA ROCHE AG 2016-03-23 — — CN disclosed
Send feedback